Zions Bancorporation National Association UT Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Zions Bancorporation National Association UT has acquired a new stake in Acadia Healthcare, purchasing 16,191 shares valued at approximately $491,000 in the first quarter.
• Shares of Acadia Healthcare have experienced a 12-month fluctuation, with a low of $17.13 and a high of $82.40; the stock opened at $19.24 recently.
• Acadia Healthcare recently reported earnings, achieving $0.83 EPS, surpassing analysts' expectations of $0.71, and a revenue of $869.23 million, representing a 9.2% year-over-year increase.

Zions Bancorporation National Association UT bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund bought 16,191 shares of the company's stock, valued at approximately $491,000.

Several other large investors have also recently modified their holdings of ACHC. GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 143.8% during the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after purchasing an additional 3,428 shares during the period. Envestnet Portfolio Solutions Inc. purchased a new position in Acadia Healthcare in the 1st quarter worth about $222,000. Sterling Capital Management LLC increased its position in shares of Acadia Healthcare by 59.1% during the fourth quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after acquiring an additional 2,026 shares during the period. Raiffeisen Bank International AG raised its stake in shares of Acadia Healthcare by 33.3% during the first quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock valued at $4,819,000 after acquiring an additional 40,000 shares in the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Acadia Healthcare in the first quarter valued at approximately $412,000.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several recent research reports. KeyCorp dropped their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Mizuho set a $22.00 price objective on Acadia Healthcare in a research report on Wednesday. Guggenheim reduced their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Barclays lowered their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Finally, Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $42.25.

Acadia Healthcare Trading Up 2.2%

NASDAQ:ACHC traded up $0.44 during mid-day trading on Wednesday, reaching $20.77. The company's stock had a trading volume of 2,941,541 shares, compared to its average volume of 2,226,614. Acadia Healthcare Company, Inc. has a twelve month low of $17.13 and a twelve month high of $82.40. The company's fifty day simple moving average is $22.05 and its two-hundred day simple moving average is $27.38. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market cap of $1.92 billion, a P/E ratio of 13.76, a P/E/G ratio of 3.96 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The company's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the business posted $0.91 EPS. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.